advertisement

WGC-2027

Drug delivery and translational research 17

Showing records 1 to 17 | Display all abstracts in Drug delivery and translational research

126192 Emerging trends in long-acting sustained drug delivery for glaucoma management
So YH
Drug delivery and translational research 2025; 15: 1907-1934
125908 In vitro tear replenishment system: assessing drug delivery from contact lens biomaterials through corneal epithelial monolayer and multilayer under replenishment conditions
Mohammadi S
Drug delivery and translational research 2025; 15: 2509-2521
125257 Chitosan-Artesunate nanoparticles: A dual anti-fibrotic and anti-inflammatory strategy for preventing bleb fibrosis post-glaucoma filtration surgery
Liu J
Drug delivery and translational research 2025; 0:
125908 In vitro tear replenishment system: assessing drug delivery from contact lens biomaterials through corneal epithelial monolayer and multilayer under replenishment conditions
Eslami S
Drug delivery and translational research 2025; 15: 2509-2521
125257 Chitosan-Artesunate nanoparticles: A dual anti-fibrotic and anti-inflammatory strategy for preventing bleb fibrosis post-glaucoma filtration surgery
Wang S
Drug delivery and translational research 2025; 0:
126192 Emerging trends in long-acting sustained drug delivery for glaucoma management
Mishra D
Drug delivery and translational research 2025; 15: 1907-1934
125257 Chitosan-Artesunate nanoparticles: A dual anti-fibrotic and anti-inflammatory strategy for preventing bleb fibrosis post-glaucoma filtration surgery
Tan G
Drug delivery and translational research 2025; 0:
126192 Emerging trends in long-acting sustained drug delivery for glaucoma management
Gite S
Drug delivery and translational research 2025; 15: 1907-1934
125908 In vitro tear replenishment system: assessing drug delivery from contact lens biomaterials through corneal epithelial monolayer and multilayer under replenishment conditions
Jones L
Drug delivery and translational research 2025; 15: 2509-2521
126192 Emerging trends in long-acting sustained drug delivery for glaucoma management
Sonawane R
Drug delivery and translational research 2025; 15: 1907-1934
125908 In vitro tear replenishment system: assessing drug delivery from contact lens biomaterials through corneal epithelial monolayer and multilayer under replenishment conditions
Gorbet M
Drug delivery and translational research 2025; 15: 2509-2521
125257 Chitosan-Artesunate nanoparticles: A dual anti-fibrotic and anti-inflammatory strategy for preventing bleb fibrosis post-glaucoma filtration surgery
Tong B
Drug delivery and translational research 2025; 0:
126192 Emerging trends in long-acting sustained drug delivery for glaucoma management
Waite D
Drug delivery and translational research 2025; 15: 1907-1934
125257 Chitosan-Artesunate nanoparticles: A dual anti-fibrotic and anti-inflammatory strategy for preventing bleb fibrosis post-glaucoma filtration surgery
Wu Y; Zhang L
Drug delivery and translational research 2025; 0:
126192 Emerging trends in long-acting sustained drug delivery for glaucoma management
Shaikh R; Vora LK
Drug delivery and translational research 2025; 15: 1907-1934
125257 Chitosan-Artesunate nanoparticles: A dual anti-fibrotic and anti-inflammatory strategy for preventing bleb fibrosis post-glaucoma filtration surgery
Jiang B
Drug delivery and translational research 2025; 0:
126192 Emerging trends in long-acting sustained drug delivery for glaucoma management
Thakur RRS
Drug delivery and translational research 2025; 15: 1907-1934

Issue 25-2

Change Issue


advertisement

WGA Rescources